Cytokinetics $CYTK
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-34
RECRUITING2
READOUTS ≤12 MONTHS1
READOUT SLIPPED >6 MO40%
Delay Index: of 5 active trials registered more than a year ago, 2 have moved their primary completion (readout) date by more than 6 months since first registration (median +3.0 months). See all sponsors →
Open Cytokinetics on the live radar map → 📅 $CYTK readout calendar (.ics)| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| ACACIA-HCM NCT06081894 |
P3 | Active, not recruiting | Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy | 500 | 2026-08-31 (+3 mo) |
| AMBER-HFpEF NCT06793371 |
P2 | Recruiting | Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF) | 60 | 2026-09 |
| COMET-HF NCT06736574 |
P3 | Recruiting | Heart Failure; Heart Failure With Reduced Ejection Fraction | 1800 | 2027-09 |
| FOREST-HCM NCT04848506 |
P2/3 | Enrolling by invitation | Symptomatic Hypertrophic Cardiomyopathy (HCM) | 900 | 2029-03 (+36 mo) |
| CEDAR-HCM NCT06412666 |
P2/3 | Active, not recruiting | Pediatric; Symptomatic Obstructive Hypertrophic Cardiomyopathy | 65 | 2030-01 (+13 mo) |